HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
The HDL hypothesis stating that simply raising HDL cholesterol (HDL-C) may produce cardiovascular benefits has been questioned recently based on several randomized clinical trials using CETP inhibitors or niacin to raise HDL-C levels. However extensive pre-clinical data support the vascular protect...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Frontiers Media S.A.
2015-09-01
|
| Ráidu: | Frontiers in Pharmacology |
| Fáttát: | |
| Liŋkkat: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00187/full |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|